Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer

详细信息    查看全文

• 作者：Nikolaus M?ckelmann (1)
  Witigo von Sch?nfels (1)
  Stephan Buch (1) (2)
  Oliver von Kampen (1)
  Bence Sipos (3)
  Jan Hendrik Egberts (4)
  Philip Rosenstiel (5)
  Andre Franke (5)
  Mario Brosch (1)
  Sebastian Hinz (4)
  Christian R?der (6)
  Holger Kalthoff (6)
  Ulrich R F?lsch (1)
  Michael Krawczak (2) (7)
  Stefan Schreiber (2) (5)
  Dieter Clemens Br?ring (4)
  Jürgen Tepel (4)
  Clemens Schafmayer (2) (4)
  Jochen Hampe (1)
  
• 刊名：BMC Gastroenterology
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：9
• 期：1
• 全文大小：1858KB
• 参考文献：1. Hemminki K, Chen B: Familial risk for colorectal cancers are mainly due to heritable causes. / Cancer Epidemiol Biomarkers Prev 2004,13(7):1253-256.
  2. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M: Familial relative risk of colorectal cancer: a population-based study. / Eur J Cancer 2003,39(13):1904-911. dx.doi.org/10.1016/S0959-8049(03)00420-9">CrossRef
  3. Johns LE, Kee F, Collins BJ, Patterson CC, Houlston RS: Colorectal cancer mortality in first-degree relatives of early-onset colorectal cancer cases. / Dis Colon Rectum 2002,45(5):681-86. dx.doi.org/10.1007/s10350-004-6267-0">CrossRef
  4. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? / Lancet 2001,357(9255):539-45. dx.doi.org/10.1016/S0140-6736(00)04046-0">CrossRef
  5. Munkholm P: Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. / Aliment Pharmacol Ther 2003,18(Suppl 2):1-. dx.doi.org/10.1046/j.1365-2036.18.s2.2.x">CrossRef
  6. Rhodes JM, Campbell BJ: Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. / Trends Mol Med 2002,8(1):10-6. dx.doi.org/10.1016/S1471-4914(01)02194-3">CrossRef
  7. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, / et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. / Nature 2001,411(6837):599-03. dx.doi.org/10.1038/35079107">CrossRef
  8. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, / et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. / Nature 2001,411(6837):603-06. dx.doi.org/10.1038/35079114">CrossRef
  9. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, / et al.: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. / Lancet 2001,357(9272):1925-928. dx.doi.org/10.1016/S0140-6736(00)05063-7">CrossRef
  10. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, / et al.: The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. / Gastroenterology 2002,122(4):867-74. dx.doi.org/10.1053/gast.2002.32415">CrossRef
  11. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, Langelier D, Pare P, Lapointe G, Cohen A, / et al.: CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. / Am J Hum Genet 2002,71(1):74-3. dx.doi.org/10.1086/341124">CrossRef
  12. Inohara N, Nunez G: The NOD: a signaling module that regulates apoptosis and host defense against pathogens. / Oncogene 2001,20(44):6473-481. dx.doi.org/10.1038/sj.onc.1204787">CrossRef
  13. McGovern DP, Hysi P, Ahmad T, van Heel DA, Moffatt MF, Carey A, Cookson WO, Jewell DP: Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. / Hum Mol Genet 2005,14(10):1245-250. dx.doi.org/10.1093/hmg/ddi135">CrossRef
  14. McGovern DP, Butler H, Ahmad T, Paolucci M, van Heel DA, Negoro K, Hysi P, Ragoussis J, Travis SP, Cardon LR, / et al.: TUCAN (CARD8) Genetic Variants and Inflammatory Bowel Disease. / Gastroenterology 2006,131(4):1190-196. dx.doi.org/10.1053/j.gastro.2006.08.008">CrossRef
  15. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska A, Debniak T, Cybulski C, Kowalska E, Szych Z: The NOD2 3020insC mutation and the risk of colorectal cancer. / Cancer Res 2004,64(5):1604-606. dx.doi.org/10.1158/0008-5472.CAN-03-3791">CrossRef
  16. Papaconstantinou I, Theodoropoulos G, Gazouli M, Panoussopoulos D, Mantzaris GJ, Felekouras E, Bramis J: Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. / Int J Cancer 2005,114(3):433-35. dx.doi.org/10.1002/ijc.20747">CrossRef
  17. Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, Frizelle FA: Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. / Cancer Res 2006,66(5):2532-535. dx.doi.org/10.1158/0008-5472.CAN-05-4165">CrossRef
  18. Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Jarvinen HJ, Karhu A, Aaltonen LA: NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. / Cancer Res 2004,64(20):7245-247. dx.doi.org/10.1158/0008-5472.CAN-04-2364">CrossRef
  19. Tuupanen S, Alhopuro P, Mecklin JP, Jarvinen H, Aaltonen LA: No evidence for association of NOD2 R702W and G908R with colorectal cancer. / Int J Cancer 2007,121(1):76-9. dx.doi.org/10.1002/ijc.22651">CrossRef
  20. Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, Fischer S, Osztovits J, Gemela O, Veres G: Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. / BMC Cancer 2007, 7:54. dx.doi.org/10.1186/1471-2407-7-54">CrossRef
  21. Krawczak M, Nikolaus S, von Eberstein H, El Mokhtari NE, Schreiber S: PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. / Community Genet 2006,9(1):55-1. dx.doi.org/10.1159/000090694">CrossRef
  22. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, / et al.: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. / Journal of the National Cancer Institute 1997,89(23):1758-762. dx.doi.org/10.1093/jnci/89.23.1758">CrossRef
  23. Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, Schreiber S: An integrated system for high throughput TaqMan based SNP genotyping. / Bioinformatics (Oxford, England) 2001,17(7):654-55. dx.doi.org/10.1093/bioinformatics/17.7.654">CrossRef
  24. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, / et al.: Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. / Lancet 2002,359(9318):1661-665. dx.doi.org/10.1016/S0140-6736(02)08590-2">CrossRef
  25. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P: A haplotype map of the human genome. / Nature 2005,437(7063):1299-320. dx.doi.org/10.1038/nature04226">CrossRef
  26. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. / Genetic epidemiology 2003,25(2):115-21. dx.doi.org/10.1002/gepi.10252">CrossRef
  27. Dupont WD, Plummer WD: PS power and sample size program available for free on the Internet. / Controlled Clin Trials 1997, 18:274. dx.doi.org/10.1016/S0197-2456(97)00074-3">CrossRef
  28. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. / Nature genetics 2005,37(11):1217-223. dx.doi.org/10.1038/ng1669">CrossRef
  29. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. / Bioinformatics (Oxford, England) 2005,21(2):263-65. dx.doi.org/10.1093/bioinformatics/bth457">CrossRef
  30. Franke A, Ruether A, Wedemeyer N, Karlsen TH, Nebel A, Schreiber S: No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. / Gut 2006,55(11):1679-680. dx.doi.org/10.1136/gut.2006.104646">CrossRef
  31. Molnar T, Hofner P, Nagy F, Lakatos PL, / et al.: NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. / Dig Liver Dis 2007, 39:1064-070. dx.doi.org/10.1016/j.dld.2007.09.003">CrossRef
  32. Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Lu T, Nikolaus S, Yang SK, Krawczak M, / et al.: Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. / Eur J Hum Genet 2003,11(1):6-6. dx.doi.org/10.1038/sj.ejhg.5200897">CrossRef
  33. Coussens LM, Werb Z: Inflammation and cancer. / Nature 2002,420(6917):860-67. dx.doi.org/10.1038/nature01322">CrossRef
  34. Shacter E, Weitzman SA: Chronic inflammation and cancer. / Oncology (Williston Park) 2002,16(2):217-26. discussion 230-12.
  35. Yamamoto-Furusho JK, Podolsky DK: Innate immunity in inflammatory bowel disease. / World J Gastroenterol 2007,13(42):5577-580.
  36. Ke X, Durrant C, Morris AP, Hunt S, Bentley DR, Deloukas P, Cardon LR: Efficiency and consistency of haplotype tagging of dense SNP maps in multiple samples. / Human molecular genetics 2004,13(21):2557-565. dx.doi.org/10.1093/hmg/ddh294">CrossRef
  37. Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. / Nat Rev Genet 2005,6(2):95-08. dx.doi.org/10.1038/nrg1521">CrossRef
  38. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, / et al.: A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. / Nature genetics 2003,35(4):349-56. dx.doi.org/10.1038/ng1268">CrossRef
  39. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, / et al.: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. / Nature genetics 2003,35(4):341-48. dx.doi.org/10.1038/ng1267">CrossRef
  40. Robert-Koch-Institut: Krebs in Deutschland 2003-004. H?ufigkeiten und Trends. / überarbeitete Auflage. Berlin: Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V 2008., 6:
  41. Claus EB, Risch NJ, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. / American journal of epidemiology 1990,131(6):961-72.
  42. Pankratz N, Byder L, Halter C, Rudolph A, Shults CW, Conneally PM, Foroud T, Nichols WC: Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. / Mov Disord 2006,21(1):45-9. dx.doi.org/10.1002/mds.20663">CrossRef
  43. Pankratz VS, de Andrade M, Therneau TM: Random-effects Cox proportional hazards model: general variance components methods for time-to-event data. / Genetic epidemiology 2005,28(2):97-09. dx.doi.org/10.1002/gepi.20043">CrossRef
  44. van Limbergen J, Nimmo ER, Russell RK, / et al.: Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. / Hum Mol Genet 2007,16(18):2175-186. dx.doi.org/10.1093/hmg/ddm169">CrossRef
  45. Bonen DK, Ogura Y, Nicolae DL, / et al.: Crohn's Disease-Associated NOD2 Variants Share a Signaling Defect in Response to Lipopolysaccharide and Peptidoglycan. / Gastroenterology 2003, 124:140-46. dx.doi.org/10.1053/gast.2003.50019">CrossRef
  46. Rosenstiel P, Till A, Schreiber S: NOD-like receptors and human diseases. / Microbes and Infection 2007, (9):648-57.
  47. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W: A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. / Nat Genet 2007,39(8):984-88. dx.doi.org/10.1038/ng2085">CrossRef
  48. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E: Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. / Nat Genet 2007,39(8):989-94. dx.doi.org/10.1038/ng2089">CrossRef
  49. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, Sullivan K: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. / Nat Genet 2008,40(5):623-30. dx.doi.org/10.1038/ng.111">CrossRef
  50. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N: Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. / Nat Genet 2008,40(5):631-37. dx.doi.org/10.1038/ng.133">CrossRef
  51. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S: A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. / Nat Genet 2007,39(11):1315-317. dx.doi.org/10.1038/ng.2007.18">CrossRef
  52. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S: Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. / Nat Genet 2008,40(12):1426-435. dx.doi.org/10.1038/ng.262">CrossRef
  53. Jaeger E, Webb E, Howarth K, Carvajal-Carmona L, Rowan A, Broderick P, Walther A, Spain S, Pittman A, Kemp Z, / et al.: Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. / Nat Genet 2008,40(1):26-8. dx.doi.org/10.1038/ng.2007.41">CrossRef
  54. Schafmayer C, Buch S, Volzke H, von Schonfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, / et al.: Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. / Int J Cancer 2009,124(1):75-0. dx.doi.org/10.1002/ijc.23872">CrossRef
  55. Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, Kelleher D, O'Sullivan M: NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? / Genes Immun 2004,5(5):417-25. dx.doi.org/10.1038/sj.gene.6364111">CrossRef
  56. The pre-publication history for this paper can be accessed here:dcentral.com/1471-230X/9/79/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-230X/9/79/prepub
  
• 作者单位：Nikolaus M?ckelmann (1)
  Witigo von Sch?nfels (1)
  Stephan Buch (1) (2)
  Oliver von Kampen (1)
  Bence Sipos (3)
  Jan Hendrik Egberts (4)
  Philip Rosenstiel (5)
  Andre Franke (5)
  Mario Brosch (1)
  Sebastian Hinz (4)
  Christian R?der (6)
  Holger Kalthoff (6)
  Ulrich R F?lsch (1)
  Michael Krawczak (2) (7)
  Stefan Schreiber (2) (5)
  Dieter Clemens Br?ring (4)
  Jürgen Tepel (4)
  Clemens Schafmayer (2) (4)
  Jochen Hampe (1)
  
  1. Department of General Internal Medicine, Christian-Albrechts-University, Kiel, Germany
  2. POPGEN Biobank project, Christian-Albrechts-University, Kiel, Germany
  3. Institute for Pathology Christian-Albrechts-University, Kiel, Germany
  4. Department of General and Thoracic, Surgery Christian-Albrechts-University, Kiel, Germany
  5. Institute of Clinical Molecular Biology Christian-Albrechts-University, Kiel, Germany
  6. Institute for Experimental Cancer Research/Comprehensiv Cancer Center North Christian-Albrechts-University, Kiel, Germany
  7. Institute of Medical Informatics and Statistics Christian-Albrechts-University, Kiel, Germany
  

文摘

Background Variation in genes involved in the innate immune response may play a role in the predisposition to colorectal cancer (CRC). Several polymorphisms of the CARD15 gene (caspase activating recruitment domain, member 15) have been reported to be associated with an increased susceptibility to Crohn disease. Since the CARD15 gene product and other CARD proteins function in innate immunity, we investigated the impact of germline variation at the CARD4, CARD8 and CARD15 loci on the risk for sporadic CRC, using a large patient sample from Northern Germany. Methods A total of 1044 patients who had been operated with sporadic colorectal carcinoma (median age at diagnosis: 59 years) were recruited and compared to 724 sex-matched, population-based control individuals (median age: 68 years). Genetic investigation was carried out following both a coding SNP and haplotype tagging approach. Subgroup analyses for N = 143 patients with early manifestation of CRC (?0 age at diagnosis) were performed for all CARD loci and subgroup analyses for diverse age strata were carried out for CARD15 mutations R702W, G908R and L1007fs. In addition, all SNPs were tested for association with disease presentation and family history of CRC. Results No significant differences were observed between the patient and control allelic or haplotypic spectra of the three genes under study for the total cohort (N = 1044 patients). None of the analysed SNPs was significantly associated with either tumour location or yielded significant association in the familial or non-familial CRC patient subgroups. However, in a patient subgroup (?5 age at diagnosis) with early disease manifestation the mutant allele of CARD15 R702W was found to be significantly associated with disease susceptibility (9.7% in cases vs 4.6% in controls; Pallelic = 0.008, Pgenotypic = 0.0008, ORallelic = 2.22 (1.21-4.05) ORressessive = 21.9 (1.96-245.4). Conclusion Variation in the innate immunity genes CARD4, CARD8 and CARD15 is unlikely to play a major role in the susceptibility to CRC in the German population. But, we report a significant disease contribution of CARD15 for CRC patients with very early disease manifestation, mainly driven by variant R702W.